Director records verified

Priyanka Agarwal

Named in 108 filings across 4 BSE-listed companies since 2025-05 — most recently at Midland Polymers Ltd (2026-10).
Records through 2026-10-10 · refreshed as new filings arrive
Seen in filings at (from BSE disclosures)
MTAR Technologies Ltd
kmp
61 filings · 2025-05 – 2026-09
Midland Polymers Ltd
New significant shareholder filings ×8
21 filings · 2025-08 – 2026-10
Cura Technologies Ltd
Board change filings ×6
13 filings · 2025-06 – 2026-09
Bandaram Pharma Packtech Ltd
Board change filings ×5
13 filings · 2025-05 – 2026-08
Documented roles (from public records)
MTAR Technologies Ltd
Company Secretary & Compliance Officer · 2026
Venmax Drugs and Pharmaceuticals Ltd
Company Secretary & Compliance Officer / signatory · earlier
Common questions (from the filings record)
Who is Priyanka Agarwal in BSE filings?
Priyanka Agarwal is named in 108 filings across 4 BSE-listed companies since 2025-05 — most recently at Midland Polymers Ltd (2026-10). Records through 2026-10-10, from public exchange disclosures.
Which companies is Priyanka Agarwal named in?
MTAR Technologies Ltd (kmp) — 61 filings, 2025-05 to 2026-09; Midland Polymers Ltd (New significant shareholder filings ×8) — 21 filings, 2025-08 to 2026-10; Cura Technologies Ltd (Board change filings ×6) — 13 filings, 2025-06 to 2026-09; Bandaram Pharma Packtech Ltd (Board change filings ×5) — 13 filings, 2025-05 to 2026-08.
What documented roles does Priyanka Agarwal hold?
From BSE filings: kmp at MTAR Technologies Ltd. From public records: MTAR Technologies Ltd — Company Secretary & Compliance Officer, 2026; Venmax Drugs and Pharmaceuticals Ltd — Company Secretary & Compliance Officer / signatory, earlier.
Track record, connections and full analysis — on the Bench
The Bench shows this person's documented history, their connections across listed companies, and what happened after their filings.
Special Situations Bench a Humdinger HQ product
Compiled from public exchange disclosures and public records. situations.humdingerhq.ai is not a SEBI-registered research analyst; nothing here is investment advice. Corrections: via Humdinger HQ.